The global dengue fever treatment industry size is expected to grow from US$ 877.82 million in 2023 to US$ 5435.25 million by 2033, at a CAGR of 20%. Dengue fever is a mosquito-borne viral infection that causes a flu-like illness. It is one of the most common mosquito-borne diseases in the world, and it is …
Category Archives: Healthcare Trends
Global Cryotherapy Industry will experience a remarkable growth to US$ 14.1 Billion by 2033, propelled by advancements in surgical techniques | Future Market Insights
As per the latest analysis report on the global cryotherapy industry demand by Future Market Insights, the market is poised for significant growth. With a projected compound annual growth rate (CAGR) of 11.2%, the cryotherapy market is expected to reach a valuation of US$ 4.9 billion by the year 2023, and by 2033, it is …
Global Scar Treatment Industry is set to achieve a valuation of US$ 52.2 Billion by 2032 with a CAGR of 13.6%, according to FMI
According to a Future Market Insights analysis report, the global scar treatment industry size is projected to reach US$ 14.6 billion in 2022. The market is anticipated to surpass US$ 52.2 billion by 2032, with a CAGR of 13.6% from 2022 to 2032. The market for hospitals is anticipated to generate the largest revenue and …
Global Biopsy Guidance Systems Industry is set to play a pivotal role in reshaping disease diagnosis techniques, with FMI forecasting a significant US$ 2 Billion by 2032
The global biopsy guidance system industry size is anticipated to create an opulent growth outlook of the market over the assessment period by registering a CAGR of 5.8% from 2022 to 2032. The global market is valued at US$ 458 Million in 2022 and is expected to surpass a valuation of US$ 2 Billion by …
Global Primary Sclerosing Cholangitis (PSC) Industry is estimated to surpass US$ 314.26 Million by 2033, according to FMI
The global primary sclerosing cholangitis (PSC) industry size is expected to be worth US$ 151.07 million in 2023. Because of rising alcohol consumption, the overall demand for Primary Sclerosing Cholangitis (PSC) is expected to grow at a CAGR of 7.6% between 2023 and 2033, totaling around US$ 314.26 Million by 2033. The Primary Sclerosing Cholangitis …
Global Postoperative Pain Industry is anticipated to achieve a valuation surpassing US$ 63.8 billion by 2033, growing at a CAGR of 5.2%, according to FMI
The global postoperative pain industry demand is expected to be valued at US$ 38.43 Billion in 2023, surpassing US$ 63.8 Billion by 2033. The market is likely projected to rise at a CAGR of 5.2% during the forecast period. The Postoperative Pain Market refers to the pharmaceutical and medical devices market focused on providing treatments and management …
Global Endoscopy Fluid Management Systems Industry with a Projected 7.4% CAGR Soar to US$ 683 Million by 2028 | FMI
The latest Future Market Insights (FMI) study reveals a steadfast trajectory for the Global Endoscopy Fluid Management Systems Industry, with Tier 1 players maintaining a commanding grip, contributing over 70% of the market revenue. The industry landscape remains highly consolidated, reflecting the prowess of key market players. In 2021, the Global Endoscopy Fluid Management Systems …
Global Vein Finder Industry Achieves Remarkable 10.9% CAGR, Targets US$ 86.8 Million by 2028 | According to FMI Analysis
The Global Vein Finder Industry, valued at approximately US$ 46.7 million in 2022, is gearing up for a remarkable surge, projecting a market valuation of US$ 86.8 million by the year 2028. According to the latest analysis by FMI, the industry is poised to experience a robust Compound Annual Growth Rate (CAGR) of 10.9% over …
Global Narcolepsy Treatment Industry Anticipates Staggering US$6.67 Billion Valuation by 2028, Felled by a 5.7% CAGR | Insights by FMI
The Global Narcolepsy Treatment Industry is poised for a substantial upswing, with projections indicating a robust growth trajectory from an estimated US$4.77 billion in 2022 to an impressive US$6.67 billion by 2028, showcasing a notable Compound Annual Growth Rate (CAGR) of 5.7% over the forecast period (2022-2028). In a recently released market intelligence overview, Future …
Global Sustained Release Excipients Industry Anticipates Unprecedented 6.8% CAGR Growth through 2026 | FMI
The Global Sustained Release Excipients Industry is poised for a remarkable expansion, with a projected Compound Annual Growth Rate (CAGR) of 6.8% expected to drive significant market demand through 2026. This growth represents a pivotal moment for the industry, marking a departure from historical trends characterized by regional competition and pricing strategies. Traditionally, the Global …